Drug Type mRNA |
Synonyms- |
Target |
Mechanism UOX modulators(urate oxidase (pseudogene) modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperuricemia | Preclinical | CN | 31 Jul 2024 | |
Hyperuricemia | Preclinical | CN | 31 Jul 2024 |